|
1
|
Sugerman PB, Joseph BK and Savage NW:
Review article: The role of oncogenes, tumour suppressor genes and
growth factors in oral squamous cell carcinoma: A case of apoptosis
versus proliferation. Oral Dis. 1:172–188. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nassar A, Lawson D, Cotsonis G and Cohen
C: Survivin and caspase-3 expression in breast cancer: Correlation
with prognostic parameters, proliferation, angiogenesis, and
outcome. Appl Immunohistochem Mol Morphol. 16:113–120. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin CY, Hung HC, Kuo RC, Chiang CP and Kuo
MY: Survivin expression predicts poorer prognosis in patients with
areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Oral Oncol. 41:645–654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lauxen IS, Oliverira MG, Rados PV, Lingen
MW, Nör JE and Sant'ana Filho M: Immunoprofiling of oral squamous
cell carcinomas reveals high p63 and survivin expression. Oral Dis.
20:e76–e80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai Y, Ma W, Huang X, Cao L, Li H, Jiang
Y, Lu N and Yin Y: Effect of survivin on tumor growth of colorectal
cancer in vivo. Int J Clin Exp Pathol. 8:13267–13272.
2015.PubMed/NCBI
|
|
6
|
Mishra R, Palve V, Kannan S, Pawar S and
Teni T: High expression of survivin and its splice variants
survivin ΔEx3 and survivin 2 B in oral cancers. Oral Surg Oral Med
Oral Pathol Oral Radiol. 120:497–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Altieri DC: The molecular basis and
potential role of survivin in cancer diagnosis and therapy. Trends
Mol Med. 7:542–547. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Axéll T, Pindborg JJ, Smith CJ and van der
Waal I: Oral white lesions with special reference to precancerous
and tobacco-related lesions: Conclusions of an international
symposium held in Uppsala, Sweden, May 18–21 1994. International
collaborative group on oral white lesions. J Oral Pathol Med.
25:49–54. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng J, Kloosterbooer F, Xia W and Hung
MC: The NH(2)-terminal and conserved region 2 domains of adenovirus
E1A mediate two distinct mechanisms of tumor suppression. Cancer
Res. 62:346–350. 2002.PubMed/NCBI
|
|
10
|
Rowley H, Sherrington P, Helliwell TR,
Kinsella A and Jones AS: p53 expression and p53 gene mutation in
oral cancer and dysplasia. Otolaryngol Head Neck Surg. 118:115–123.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duffy MJ, O'Donovan N, Brennan DJ,
Gallagher WM and Ryan BM: Survivin: A promising tumor biomarker.
Cancer Lett. 249:49–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lo Muzio L, Pannone G, Leonardi R,
Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T and Altieri
DC: Survivin, a potential early predictor of tumor progression in
the oral mucosa. J Dent Res. 82:923–928. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poomsawat S, Punyasingh J and Vejchapipat
P: Overexpression of survivin and caspase 3 in oral carcinogenesis.
Appl Immunohistochem Mol Morphol. 22:65–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grossman D, McNiff JM, Li F and Altieri
DC: Expression of the apoptosis inhibitor, survivin, in nonmelanoma
skin cancer and gene targeting in a keratinoyte cell line. J Lab
Invest. 79:1121–1126. 1999.
|
|
15
|
Li SX, Chai L, Cai ZG, Jin LJ, Chen Y, Wu
HR and Sun Z: Expression of survivin and caspase 3 in oral squamous
cell carcinoma and peritumoral tissue. Asian Pac J Cancer Prev.
13:5027–5031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kania J, Konturek SJ, Marlicz K, Hahn EG
and Konturek PC: Expression of survivin and caspase-3 in gastric
cancer. Dig Dis Sci. 48:266–271. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang ZM, Zhao ZG, Guan XM, Liu F and Zhang
LP: Expression of Survivin mRNA and Caspase-3 mRNA and their
correlation in tongue squamous cell carcinoma. Shanghai Kou Qiang
Yi Xue. 16:582–586. 2007.(In Chinese). PubMed/NCBI
|
|
18
|
Xu JH, Wang AX, Huang HZ, Wang JG, Pan CB
and Zhang B: Survivin shRNA induces caspase-3-dependent apoptosis
and enhances cisplatin sensitivity in squamous cell carcinoma of
the tongue. Oncol Res. 18:377–385. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holdenrieder S and Stieber P: Circulating
apoptotic markers in the management of non-small cell lung cancer.
Cancer Biomark. 6:197–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang JY, Casiano CA, Peng XX, Koziol JA,
Chan EK and Tan EM: Enhancement of antibody detection in cancer
using panel of recombinant tumor-associated antigens. Cancer
Epidemiol Biomarkers Prev. 12:136–143. 2003.PubMed/NCBI
|
|
21
|
Srinivasprasad V, Dineshshankar J,
Sathiyajeeva J, Karthikeyan M, Sunitha J and Ragunathan R: Liaison
between micro-organisms and oral cancer. J Pharm Bioallied Sci.
7:(Suppl 2). S354–S360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hills SA and Diffley JF: DNA replication
and oncogene-induced replicative stress. Curr Biol. 24:R435–R444.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang S, Xu J and Zhang Q: Clinical
significance of survivin and vascular endothelial growth factor
mRNA detection in the peripheral whole blood of breast cancer
patients. Neoplasma. 63:133–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao J, Huang Y, Li M, Zhao H, Zhao Y, Li
R, Yan J, Yu Y and Qiao J: Effect of local basic fibroblast growth
factor and vascular endothelial growth factor on subcutaneously
allotransplanted ovarian tissue in ovariectomized mice. PLoS One.
10:e01340352015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji ZJ, Wang JL and Chen L: Inhibition of
skin squamous cell carcinoma proliferation and promote apoptosis by
dual silencing of NET-1 and survivin. Oncol Rep. 34:811–822.
2015.PubMed/NCBI
|
|
26
|
Coma S, Noe V, Lavarino C, Adán J, Rivas
M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J and
Ciudad CJ: Use of siRNAs an d antisense oligonucleotides against
survivin RNA to inhibit steps leading to tumor angiogenesis.
Oligonucleotides. 14:100–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tu SP, Cui JT, Liston P, Huajiang X, Xu R,
Lin MC, Zhu YB, Zou B, Ng SS, Jiang SH, et al: Gene therapy for
colon cancer by adeno-associated viral vector-mediated transfer of
surviving Cys84Ala mutant. Gastroenterology. 128:361–375. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cosgrave N, Hill AD and Young LS: Growth
factor-dependent regulation of survivin by c-myc in human breast
cancer. J Mol Endocrinol. 37:377–390. 2006. View Article : Google Scholar : PubMed/NCBI
|
